CareDx Downgraded by StockNews.com to Hold
| CDNA Stock | USD 20.89 0.48 2.25% |
About 61% of Caredx's investor base is looking to short. The analysis of the overall investor sentiment regarding Caredx Inc suggests that many traders are alarmed. The current market sentiment, together with Caredx's historical and current headlines, can help investors time the market. In addition, many technical investors use Caredx Inc stock news signals to limit their universe of possible portfolio assets.
Caredx |
StockNews.com lowered shares of CareDx from a buy rating to a hold rating in a research report report published on Wednesday morning. A number of other research firms also recently commented on CDNA. BTIG Research raised shares of CareDx from a neutral rating to a buy rating and set a 40.00
Read at thelincolnianonline.com
 |
Caredx Fundamental Analysis
We analyze Caredx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Caredx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Caredx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Target Price
Target Price Comparative Analysis
Caredx is currently under evaluation in target price category among its peers.
Caredx Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Caredx stock to make a market-neutral strategy. Peer analysis of Caredx could also be used in its relative valuation, which is a method of valuing Caredx by comparing valuation metrics with similar companies.
Peers
Caredx Related Equities
| PSNL | Personalis | 5.91 | ||||
| CSTL | Castle Biosciences | 3.79 | ||||
| BDSX | Biodesix | 3.75 | ||||
| CRL | Charles River | 0.51 | ||||
| SERA | Sera Prognostics | 0.48 | ||||
| TWST | Twist Bioscience | 0.95 | ||||
| DRIO | DarioHealth Corp | 1.43 | ||||
| NTRA | Natera | 1.50 | ||||
| MYGN | Myriad Genetics | 1.53 | ||||
| ILMN | Illumina | 1.79 | ||||
| EXAS | EXACT Sciences | 2.15 | ||||
| GH | Guardant Health | 4.92 |
Complementary Tools for Caredx Stock analysis
When running Caredx's price analysis, check to measure Caredx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Caredx is operating at the current time. Most of Caredx's value examination focuses on studying past and present price action to predict the probability of Caredx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Caredx's price. Additionally, you may evaluate how the addition of Caredx to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |